Seah H. Lim - 04 Oct 2022 Form 3/A Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Director
Signature
Seah H. Lim
Issuer symbol
EMMA
Transactions as of
04 Oct 2022
Net transactions value
$0
Form type
3/A
Filing time
20 Dec 2023, 10:33:33 UTC
Date Of Original Report
06 Oct 2022
Next filing
19 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EMMA Common stock, $0.001 par value 38,500 04 Oct 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EMMA Promissory Note due 9/16/2025 04 Oct 2022 Common Stock 240,000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3/A is being filed to correct the number of shares of common stock beneficially owned directly by the Reporting Person, which was erroneously not reported on a Form 3 filed on October 6, 2022.
F2 The shares shown are issuable upon maturity of the promissory note or earlier prepayment of the note.